Biggest News Aggregation in the World
📰 Ercent News

Page 56 - Ercent News Today

Fast, Ad-Free News Updates

Stay updated with breaking news from Ercent. Real-time updates on events, politics, business and more.

EPKINLY™ (epcoritamab-bysp) Approved by U.S. Food and Drug Administration as the First and Only Bispecific Antibody to Treat Adults with Relapsed or Refractory (R/R) Diffuse Large B-cell Lymphoma (DLBCL)

Company Announcement Results from phase 2 clinical trial demonstrated EPKINLY™ delivered 61 percent overall response rate, 38 percent complete response, and 15.6-month median duration of... | May 19, 2023
New Jersey United States Meghan Gutierrez Andrew Carlsen Tycel Phillips Kalvebod Brygge

Stay Updated with Latest News

Get breaking news updates delivered to your inbox

Browse All News →

Explore More Categories

World News India News Business Technology Sports Entertainment Health Science